Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    "Congenital antithrombin deficiency"
Show Display Options
Download search resultsDownload the search results for:
"Congenital antithrombin deficiency" (3 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed A Study of KW-3357 in Congenital Antithrombin Deficiency
Condition: Congenital Antithrombin Deficiency
Intervention: Drug: KW-3357
2 Completed
Has Results
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
Condition: Antithrombin Deficiency, Congenital
Intervention: Biological: Recombinant Human Antithrombin (rhAT)
3 Completed
Has Results
Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
Condition: Antithrombin III Deficiency
Intervention: Biological: Recombinant human antithrombin (rhAT)

Indicates status has not been verified in more than two years